相关实验视频

Updated: Sep 9, 2025

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Published on: July 26, 2024

在阿尔茨海默氏症中微细胞与神经元的相互作用

Yujie Ma¹, Xinyue Wang^2,3, Minghuang Gao¹

¹Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

Current neuropharmacology

|August 28, 2025

概括

微质在阿尔茨海默氏症 (AD) 中起着双重作用,这是一种渐进的神经退行性疾病. 了解微细胞与神经元之间的相互作用为阿尔茨海默病提供了新的治疗点.

科学领域:

神经科学
免疫学
病理学

背景情况:

阿尔茨海默病 (AD) 涉及神经元损失和功能障碍,导致认知能力下降.
大脑的免疫细胞微细胞越来越多地参与神经元命运, 但它们在AD病变中的确切作用尚不清楚.
现有的AD假设包括粉样层,蛋白,神经炎症和金属离子.

研究的目的:

审查微细胞与神经元相互作用在阿尔茨海默氏症发病过程中的作用.
在AD神经元退化中探索微质介导的突触修剪和代谢合.
在已建立的AD病原性框架内总结微细胞与神经元的相互作用.

主要方法:

关于微质和阿尔茨海默病的科学研究的文献综述.
分析微质作为神经元保护者和损伤加剧者的双重作用.
与突触修剪,代谢合和AD特征相关的发现的综合.

主要成果:

微细胞对阿尔茨海默氏症患者的神经元健康具有双向影响.
过度的突触修剪会导致神经元损失.
微细胞与神经元的代谢合是AD神经元退化的一个关键因素.
微质的作用与粉样蛋白,蛋白,神经炎症和金属离子假设相结合.

结论:

在阿尔茨海默氏症神经元退化中,微细胞与神经元的相互作用至关重要.
微可以保护和损害神经元, 这取决于环境.
针对微细胞与神经元之间的沟通为阿尔茨海默氏症提供了一个新的治疗途径.

关键词:

阿尔茨海默病这是一个古典的假设.代谢合微质细胞神经元退化突触剪切

更多相关视频

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Glial Cells

Glial Cells